(NaturalNews)
(Natural News) Since 2016, pharmaceutical giant AbbVie has generated more than $114 billion in revenue from the sale of its anti-inflammatory drug Humira. That same year, Humira was supposed to go off-patent and become generic – meaning it would have cost a whole lot less for consumers – but because of patent manipulation, AbbVie has been … [Read More…] |
Related posts:
New Report Shows TPP Will Increase Incomes at the Cost of US Jobs
Britain and Saudi Arabia: Partners in High Crimes
Pfizer Makes $43 Billion Bet That ‘Turbo Cancers’ Will Continue Exploding Around The World
The Hijacked Mind: Healing a Society in Trauma
The Problem with Mental Health & Gun Violence No One Wants to Talk About
The Problem with Mental Health & Gun Violence No One Wants to Talk About